Diane Myers - Baudax Bio VP Quality

BXRXDelisted Stock  USD 0.76  0.06  7.32%   

Insider

Diane Myers is VP Quality of Baudax Bio
Age 59
Phone484 395 2440
Webhttps://www.baudaxbio.com

Baudax Bio Management Efficiency

The company has return on total asset (ROA) of (1.1493) % which means that it has lost $1.1493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (47.0421) %, meaning that it created substantial loss on money invested by shareholders. Baudax Bio's management efficiency ratios could be used to measure how well Baudax Bio manages its routine affairs as well as how well it operates its assets and liabilities.
Baudax Bio currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax Bio has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Baudax Bio's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Gerald ProehlDermata Therapeutics
65
Robert McRaePalisade Bio
N/A
MSE MBAEnsysce Biosciences
52
Professor MDAllarity Therapeutics
67
MD DrScAllarity Therapeutics
81
Michael MyersQuoin Pharmaceuticals Ltd
62
Joan BrownAllarity Therapeutics
70
Marcel CPAAltamira Therapeutics
66
Samuel MDAltamira Therapeutics
71
Linda PestanoEnsysce Biosciences
55
John CPAWindtree Therapeutics
60
MD FAAAAIPalisade Bio
N/A
CPA CTPCns Pharmaceuticals
44
David HaleDermata Therapeutics
75
Denise CarterQuoin Pharmaceuticals Ltd
55
Tracy RarickWindtree Therapeutics
N/A
PharmD BCPSNeurobo Pharmaceuticals
N/A
James FosterVirax Biolabs Group
39
Waldemar PriebeCns Pharmaceuticals
N/A
Sharon McBrayerPalisade Bio
N/A
Jean LechanceAltamira Therapeutics
N/A
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people. Baudax Bio (BXRX) is traded on NASDAQ Exchange in USA and employs 9 people.

Management Performance

Baudax Bio Leadership Team

Elected by the shareholders, the Baudax Bio's board of directors comprises two types of representatives: Baudax Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baudax. The board's role is to monitor Baudax Bio's management team and ensure that shareholders' interests are well served. Baudax Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baudax Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Natalie McAndrew, Consultant Officer
Jillian Dilmore, Corp Controller
Diane Myers, VP Quality
Chan Yong, Chief Director
Geraldine Henwood, CEO President
Mike Choi, Vice Analysis

Baudax Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Baudax Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in Baudax Stock

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges